Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
19/04/2016
Investigation of air pollution
biomarkers for use in the SCAMP study
Kings College London
Rosamund Dove
Project Overview:
Theme 4, Project 2: Neurocognitive and behavioural impacts of traffic derived pollutants in
children.
Ian Mudway (King’s); Mireille Toledano (Imperial); Karen Exley, PHE
• Investigate the potential of urinary metal concentrations as biomarkers of
traffic exposure
• Investigate the impact of air pollution on cognitive development during
adolescence
Dispersion models are now available for 2014 and 2015; these models can be used to estimate annual exposures
(PM2.5, PM10, NOx and NO2) for the 12 months prior to cognitive assessment (SCAMP - Theme III/Project 2 –
Electromagnetic fields; Mireille Toledano (Imperial), Simon Bouffler (PHE))
Background – Cognitive effect?
LIFE
Long term
BIRTH
Early LifePrenatal
• IQ (Perera 2009)• “Cognitive
dysfunction” (Jedrychowski 2015)
• Autism (Wong 2015)
• “cognitive performance” (Wang 2009, Freire 2010, Suglia 2008, Harris 2015, Calderon-Garciduenas 2011)
• ADHD (Newman 2013, Siddique 2011)• Autism (Becerra 2013, Roberts 2013, Volk
2011, 2013)
• “cognitive function” (Schikowski2015, Weuve 2012, Power 2011, Ranft 2009, Porta 2015, Sunyer 2015)
• Stroke (Kettunen 2007)• Depression (Banarjee 2012, Lim 2012)• Dementia (Chang 2014, Oudin 2015)• Alzheimer’s (Oudin 2015)• Parkinson’s – (Ritz 2015)
Sensory
Language
Higher
cognitive
functions
Cognitive Impact?• Verbal/non-
verbal
intelligence
• Processing
speed
• Working
memory
• Short-term
memory
• Sustained
attention
• Cognitive
flexibility
• Visual-motor
integration
• Fluid reasoning
• sample size
• co-variates
(noise, diet etc),
• Longitudinal
study design
• PM10
• PM2.5
• NO2
• NOx
• Black carbon
• Ozone
• CO
• Distance to
major road
• Home/school;
indoor/outdoor
Background – Cognitive effect?
SCAMP – Study Design
Baseline (Year 1/HPRU Year 2) and Follow-up (Year 3/HPRU Year 4)
Exposure
modelling
(NO2, NOx,
PM10, PM2.5)
SCAMP team (school visits)
• Dr. Gemma Knowles (Imperial)
• Charlotte Fleming (Imperial)
• Irene Chang (Imperial)
• Dr. Rosamund Dove (KCL)
• Mark Ellis (Imperial)
• Rosi Hirst (Imperial)
Parent mailing
SCAMP Cohort = All Year 7 pupils from participating schools (n = ~5500)
School assessment
Child online surveyParental consent Cognitive ability, mobile phone
use, and lifestyle
Medical history, lifestyle,
demographics Routine records:
1. Educational
achievement
2. Traffic data
3. Health data
Parent online
survey
Subset of the SCAMP
cohort (~200)In-depth personal
radiofrequency exposure
monitoring (opt-in)
Traffic data
Smartphone ‘apps’
Personal & environmental measurements
QuestionnairesActivi
ty diary GPS
Biosamples
SCAMP – Personal Monitoring
To take place during
SCAMP year 2/HPRU
Year 3
Theme 3,
Project 2:
• Stress
biomarkers
• ETS
• hormones
Theme 4,
Project 2:
• Oxidative
stress
• Urinary
biomarkers
Biomarkers
Response biomarkers
(generic)• Oxidative stress: 8-Oxo-2'-
deoxyguanosine, 8-isoprostane
• Systematic inflammation: IL-6, CRP
• Neuroinflammation/injury: neuron specific
enolase, S100B
Exposure
biomarkers• PAHs and hydroxylated PAHs
• Metals
• Cotinine
• Chemical entity that demonstrates a gradient with respect to
traffic
• Stable/readily measurable in accessible biofluids
• Should align with established exposure metrics
• High throughput/low cost
• Sensitive/specific methodology
• Reproducible
Biomarkers
PM10, PM2.5, PNC, black
carbon
PM10, PM2.5,
NO2, NOx
EXHALE
Proxy personal monitoring data
Urinary metals - (2008-2011)
Modelled exposure(using home
address)
Urinary metals - (2012)
Metal Analysis – (ICPMS)
• Brake-wear – Ba, Cu, Sb
• Mechanical wear – Fe, Mn,
Sn, Zn
• Exhaust wear – Cr, Mo, Ni,
Pb, V
Exposure Biomarkers
Association of urinary Fe with
modelled pollutant exposures
Roadside PM10 Fe (2008/9) • Modelled annual exposure
(20x20m resolution) based
on residential address.
• Shorter duration exposure
estimated based on
NOWCAST (24 h and 7
days pre-visit) adjustment of
the annual model.
• Generalized linear latent and
mixed model assuming a
gamma distribution with log
link
• Adjusted for air pollutant,
sex, ethnicity, ETS and
study year with a random
effect for school
Exposure Biomarkers
Association of urinary Cu
with modelled pollutant
exposures
Roadside PM10 Cu (2008/9)
Exposure Biomarkers
Roadside PM10 Mn (2008/9)
Association of urinary Mn
with modelled pollutant
exposures
Biomarkers – Personal Exposure
Children’s routes
were selected based
on GIS modelling of
shortest route
between the school
and the home
address
Frequency of routes
walked
PM2.5
Biomarkers – Personal Exposure
Children’s routes
were selected based
on GIS modelling of
shortest route
between the school
and the home
address
Black Carbon Ultra fine particle No
Future Work
• Analysis of the EXHALE Year 4 samples will be completed in April 2016.
• 3rd data set – Airway Cells and Air Pollution (ACAP) study examined the effect
of PM on airway macrophages and dendritic cells in children aged 8-14 years.
Sputum samples were analysed for the presence of black carbon in
macrophages. Urinary metal analysis will completed April/May 2016
• Personal monitoring and sample collection for Year 2 of the SCAMP study is
ongoing. Analysis of these samples is expected to begin October/November
2016
• Hydroxylated PAHs – method development for determination in low volume
samples based on solid phase extraction, dansyl chloride derivatization and
liquid chromatography-tandem mass spectrometry detection. (Yao L et al.
Anal. Methods, 2014, 6, 6488)
Acknowledgements
KCL:
• Frank kelly
• Ian Mudway
• Heather Walton
• Chrissi Dunster
• Ana Oliete
Dominguez
• Andrew
Cakebread
• Asra Alwandi
ACAP:
• Prof Jonathan
Grigg
• Dr Abigail
Whitehouse
SCAMP Team
Imperial:
• Mireille Toledano
• Paul Elliott
• Charlotte Fleming
• Irene Chang
• Will Mueller
• Iroise Dumontheil (Birkbeck)
• Michael Thomas (Birkbeck)
• Martin Röösli (Swiss TPH)
19/04/2016
Response of human airway epithelial cells to
diesel exhaust particles and cerium dioxide
and silver nanoparticles
Chang Guo (PHE), Kirsty Meldrum (IC/PHE), Lareb Dean (IC),
Martin Leonard (PHE), Rachel Smith (PHE), Terry Tetley (IC)
Theme IV – Project 4
Health Impacts - Nanoparticles
Introduction
• Health impact of nanomaterials – to understand the potential health effects of
nanoparticle exposure and to address the knowledge gaps
• Animal models used but have disadvantages as well as advantages
• In vitro modelling is useful to identify pathways and therapeutic targets
• Use of novel “human” organotypic experimental models becoming more relevant
Theme IV – Project 4
Health Impacts - Nanoparticles
Progress FY15/16
• Milestone 1 – The ALI-AE system/protocols have been modified/developed to
facilitate robust operation. A549 cells, human primary small airway epithelial
(HPSAE) cells and organotypic reconstituted 3D HPSAE cultures have been
exposed to AgNPs and characterised for adverse effects (general cytotoxicity
and expression of select mRNAs/miRNAs).
• Milestone 2 – In vitro system to explore the effect of NPs on allergic effects in
development - initially maintaining ALI control cultures of organotypic
reconstituted 3D human bronchial epithelium.
• Milestone 3 - In vitro 3D co-culture model of the human alveolar unit (comprising air
and blood compartments) established, characterised and development completed.
• Milestone 4 - Consolidated studies of the effects of carbon nanotubes on cell
viability, oxidative stress, inflammation, and pro-thrombotic mediators.
Project 4 – Milestone 1
• The increasing use of silver nanoparticles (AgNPs) in consumer products
has raised concerns about potential toxic effects through inhalation.
• Our previous in vivo study indicates the small airways are important for
AgNP exposure.
• Develop exposure system combined with optimised human cultures to
provide important toxicity relevant information.
ALI-AE System(Air Liquid Interface - Aerosol Exposure System)
AgNP aerosol
deposition device
in vitro cell models
Cell culture media
Precipitator module
Charger module
ALI-AE System Schematic
Exposure conditions:Electrostatic charger voltage: -150 V
Deposition efficiency: ~40%
Cell temperature: 37 ºC
Delivered gas CO2 content: 5%
Delivered gas O2 content: 20%
Delivered gas relative humidity: >80%
0.005lpm 0.005lpm
0.005lpm
1lpm
Gas monitors:
RH=>80%
O2=20%
CO2=5%
24mm Transwell inserts
AgNP aerosol deposition checked by
Laser Ablation ICP-MS
12mm Transwell inserts
Ag
10
7A
g 1
07
Diameter (mm)
Diameter (mm)
+AgNPs + Air
6.5mm Transwell inserts
AgNP Aerosol Characterisation and Dose
Group Exposure Length
(mins)
Mass conc.
(µg/m3)
Number conc.
(#/cm3)
CMD
(nm)
GSD Dose
(particles/cell*)
Ag dose 1
(LD)7 180 1.5 x 106 15.5 1.36 ~220
Ag dose 2
(HD)20 180 1.5 x 106 15.5 1.36 ~660
Air 7 - 50 - - 0
Air 20 - 50 - - 0
*Assuming 2 x 106 cells/well
Average number-weighted aerosol size distribution for all exposures measured with an SMPS.
Representative
TEM image of
particles
deposited onto
grids placed at
the bottom of the
wells (with no
cells). Larger
objects are part
of grid structure.
In vitro models used in the ALI-AE system
A549 cells
Small Airway Epithelia
H/E Alcian Blue staining
CC-10 Staining
(marker of Club Cells)
MUC-5AC staining
(marker of Goblet cells)
Small airways
Internal diameter <2mm
Generation >8
Non-cartilagineous
Relevant diseases :
brochiolitis, asthma, COPD
General toxicity of epithelial cells exposed
to AgNP aerosols in ALI-AE system
0
1
2
3
Air AgNPs
24 hrs post exposure
No
rmal
ized
cel
l via
bili
tyN
orm
aliz
ed c
ell v
iab
ility
0
0.5
1
1.5
2
unexposed Air AgNPs unexposed Air AgNPs
6 hrs post exposure 24 hrs post exposure
LD
HD
A549 cells
Small Airway Epithelia (one donor)
*
Selected mRNA and miRNA expression in
epithelial cells exposed to AgNP aerosols
A549 cells
6 hrs
LD
HD
24 hrs
LD
HD
5.08
18
509
58A
lox1
5
1.9
54
76
301
De
fb4
-1.03
39
45
86
4B
atf
-1.6
27
608
045C
hi3
l1
2.3
92
46
84
69C
3
-1.1
71
101
58
9C
elc
10a
-1.6
48
77
95
57C
cl17
-1.8
202
68
44
2C
lec4
a
5.1
61
45
096
2C
cl2
-2.2
97
71
98
24C
elc
5a
-1.3
53
74
28
98C
cl24
1.1
54
27
19
62C
xcl1
-1.4
81
19
076
4C
cl7
-1.7
57
87
55
65C
xcl2
1.1
91
92
77
24C
xcl5
-2.02
46
41
59
1It
gam
-1.4
96
28
507
9D
uo
x1
-1.7
78
48
75
21H
mo
x1
-5.04
55
83
45
9Fa
bp
5
-1.8
11
25
52
58Li
lib
4
-1.5
72
91
25
87Fc
gr2b
-1.4
606
96
87
6M
mp
12
-2.8
36
95
64
66Fo
xp3
-1.7
802
63
24
1Lc
n2
1.2
48
29
89
33M
uc1
1.5
32
47
46
92N
oxo
1
-4.2
605
43
058Ll
ib
-1.1
63
103
16
8M
t1a
1.6
46
91
12
04M
t2a
-2.9
27
49
12
03Sl
c39a
1.7
108
41
67
2Sf
tpd
-1.1
88
42
602
1Sl
c26a
-1.8
31
36
37
84R
ab7b
-1.7
18
905
57
2Ta
c1
-1.4
096
96
77
9R
nas
e9
3.1
85
78
33
73Ta
c4
-9.1
18
39
45
1S1
00a9
1.1
63
19
27
75Tl
r10
-3.04
64
45
039Se
pin
b10
-1.1
58
28
43
21Tn
faf8
-1.8
22
94
77
91O
rm1
-1.4
38
27
79
49Tr
em
1
-1.2
59
62
21
47C
cl22
-3.1
44
86
94
32Tr
em
2
-1.06
93
013
61Sp
p1
-1.5
53
17
301
4C
hia
-4.1
22
29
25
77M
reg
-1.7
47
98
21
59Il
r2
-4.4
58
16
47
2C
ep
55
-2.01
66
53
19m
ir12
98
2.5
49
52
44
91m
ir14
6b
-1.7
38
600
18
9m
ir22
4
-1.1
41
67
309
8m
ir21
24 hrs
HD
Small Airway Epithelia
Alo
x15
De
fb4
Bat
f
Ch
i3l1
C3
Ce
lc10
a
Ccl
17
Cle
c4a
Ccl
2
Ce
lc5a
Ccl
24
Cxc
l1
Ccl
7
Cxc
l2
Cxc
l5
Itga
m
Du
ox1
Hm
ox1
Fab
p5
Lili
b4
Fcgr
2b
Mm
p12
Foxp
3
Lcn
2
Mu
c1
No
xo1
Llib
Mt1
a
Mt2
a
Slc3
9a
Sftp
d
Slc2
6a
Rab
7b
Tac1
Rn
ase
9
Tac4
S100
a9
Tlr1
0
Sep
inb
10
Tnfa
f8
Orm
1
Tre
m1
Ccl
22
Tre
m2
Spp
1
Ch
ia
Mre
g
Ilr2
Ce
p55
mir
1298
mir
146b
mir
224
mir
21
-2.485145696
-1.372825537
2.252008228
1.364345806
-1.166046226
-1.045613486
1.710371124
-1.046524504
-1.428463259
-1.039023095
1.869185915
1.202048617
-1.102204453
1.128706376
1.723235074
-1.121214365
-1.214062688
-1.142229781
2.673690562
1.035631405
1.057389708
1.09017957
1.958289113
1.048984713
1.102792228
1.176931416
2.445641281
1.673126441
-1.005609924
1.327102666
2.426105853
1.284554068
1.414018939
-1.456239172
1.482868051
1.28415847
-1.032868429
-1.005109018
2.140320474
-1.029464188
1.168252888
1.297743773
2.046380908
1.174367029
1.289545631
-1.130463769
1.619601385
1.071380629
1.001724208
1.004343886
1.471610368
1.289044114
-1.05837093
1.151278222
2.039954991
1.354821872
1.052327031
-1.148620578
1.657912887
1.165026675
1.347474235
1.625521308
4.183313531
-1.001605856
1.037868982
1.199571983
2.045289825
1.026582479
1.880766243
1.338837462
1.584156204
-1.230141873
-1.021895275
1.803776389
2.273164385
1.421749839
-2.430285306
1.185384829
2.569043965
-3.061887022
1.034764071
1.159345065
2.093764798
1.132277921
7.786700218
-1.998510833
1.327587854
1.493454502
-1.386660887
1.165865336
1.714695996
1.325271222
1.697022934
1.280948922
-1.153736757
-1.153736757
-1.151307696
1.349065807
2.375417472
1.038059017
-1.461160478
-3.206707836
7.854610461
3.356945276
1.021072457
1.037773552
1.111885699
1.132698684
1.350957666
1.233304076
1.245042353
-1.123805525
-2.120976922
-1.644621317
2.973292506
1.239298363
-1.028013697
-1.172574418
3.106925136
1.214804997
-2.255142814
-2.537732765
2.393173391
1.226625976
-2.729103026
-2.460612146
2.555738153
2.028560514
-1.679977838
-1.824107693
2.507135954
1.088554946
-1.342985189
-1.240666984
5.238212433
1.290698485
-1.768810275
-1.57982454
2.154128153
1.476421077
-1.17811014
-1.28276879
5.050926526
1.461712363
-1.419214198
-1.345806777
3.00689699
1.12021115
-1.441180516
-1.392554688
1.614099319
-1.021454449
-2.911577529
-2.587593681
5.463250401
1.793842874
-1.302768624
-1.002232997
5.061631573
1.355528308
-1.79182945
-1.644878596
2.876206681
1.292727071
-1.296440388
-1.243858539
2.670416766
-1.571115623
-1.016410737
-1.028129865
2.547385959
1.291115261
-1.078969138
1.108417865
1.661554512
1.004345052
1.056937376
1.034587806
1.364670868
-1.061624485
1.024595706
1.412203885
1.597749036
1.188259368
-1.073809951
1.033303915
1.983499067
-1.033690741
-1.229538935
-1.005406092
2.050223806
1.084492081
-2.757774051
1.100221251
1.485606566
-1.019928958
-1.979862603
-1.92977435
-2.383655035
-2.940424196
-1.440349575
-2.667523141
-1.62046781
-1.372818362
-1.120358123
-2.464025542
-1.388162553
-1.529254489
-1.235223873
-2.84264225
-1.321816086
1.063853226
Summary and Future Work
• Finalize optimisation of ALI-AE system.
• Complete exposures of the Small Airway Epithelia.
• Identify key pathways reflective of specific toxicity relevant for human
hazard identification.
• To give a more complete picture of the hazard posed by these NPs.
• Investigate other nanomaterials using the system
Project 4 – Milestone 2
• The increasing use of cerium dioxide nanoparticles (CeO2NPs) as
catalysts within diesel engines
– Have been used as a catalyst since 1999
– Changes what is expelled from the exhaust
– Bus fleets in Newcastle and London
• Using optimised human cultures to investigate potential allergic
effects addition of cerium dioxide NPs to diesel engines may cause
• Aim to determine whether cerium dioxide impacts on DEP-induced
toxicity in a model of primary human bronchial airway epithelium
PE membrane
Transwell insert
Apical chamber
HPBE
Basal chamber
Diesel (NIST 2975)
CeO2NPs (Sigma <25nm)
DEP+CeO2NPs
24 hours
Basal
compartment
mediumApical
compartment
medium
CCL20
IL-6
CCL20
IL-6Human Primary
Bronchial
Epithelial Cells
(HPBECs)
Experimental model DEP, CeO2NPs and
DEP+CeO2NPs exposure, at concentrations
relevant to normal Envirox use.
IL-6 - pleiotropic cytokine; CCL20 – dendritic cell chemoattractant
Basal and apical release of CCL20 (green) and IL-6
(pink) by HPBECs following exposure to DEP,
CeO2NPs and DEP/CeO2NP
DEP
CeO2NP
DEP/CeO2NP
Summary and Future Work
• IL-6 release decreased with exposure of DEP/CeO2NPs when compared to
CeO2NPs alone
• Basal, but not apical, release of CCL20 was blocked on exposure to
DEP/CeO2NPs but not on exposure to DEP or CeO2NPs alone.
• Significant effect of addition of CeO2NPs to diesel fuel on large airway
inflammation and allergic responses?
• Fully characterize HPBEC model
• Study other markers of inflammation and allergy – IL-8, TSLP etc
• Continue to investigate the potential hazards the addition of these NPs may
pose
• Preparation of a review article in progress (nanoparticles and asthma)
Thanks for Listening
Chang Guo (PHE), Kirsty Meldrum (IC/PHE),
Lareb Dean (IC), Martin Leonard (PHE),
Rachel Smith (PHE), Terry Tetley (IC)